Mayne Pharma Group Ltd.ASX: MYX

Update on status of FIRB approval and second court hearing

· Issued by Mayne Pharma Group Ltd.

Filed with ASX · · 2 pages · English

Summary by 6ix AI

Mayne Pharma Group Ltd. has announced an update regarding its acquisition by Cosette Pharmaceuticals, Inc., specifically on the status of FIRB approval and the scheduling of a second court hearing. The FIRB has extended the deadline for approval, and the court hearing is now set for a specific date and time. The announcement includes an indicative timetable for the acquisition process, which remains subject to various approvals and conditions.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Mayne Pharma Group Ltd. on 6ix

Story so far

Earlier from Mayne Pharma

Later from Mayne Pharma

All Mayne Pharma news releases